Details of the Drug

General Information of Drug (ID: DMZBU2M)

Drug Name
Triazavirin
Synonyms Riamilovir; Riamilovir [INN]; Triazavirin [WHO-DD]
Indication
Disease Entry ICD 11 Status REF
Influenza virus infection 1E30-1E32 Phase 2 [1]
Coronavirus Disease 2019 (COVID-19) 1D6Y Investigative [2]
Affected Organisms
Influenza A virusInfluenza B virus
Drug Type
Small molecular drug
Structure
3D MOL 2D MOL
Chemical Identifiers
Formula
C5H4N6O3S
Canonical SMILES
CSC1=NC2=NN=C(C(=O)N2N1)[N+](=O)[O-]
InChI
InChI=1S/C5H4N6O3S/c1-15-5-6-4-8-7-2(11(13)14)3(12)10(4)9-5/h1H3,(H,6,8,9)
InChIKey
IDVQGNMSSHPZSJ-UHFFFAOYSA-N
Cross-matching ID
PubChem CID
3113817
CAS Number
123606-06-4
UNII
F2HTG1MH2D
DrugBank ID
DB15622
TTD ID
D07IYO
Repurposed Drugs (RPD) Click to Jump to the Detailed RPD Information of This Drug

References

1 A New Antiviral Drug Triazavirin: Results of Phase II Clinical Trial. Vopr Virusol. Nov-Dec 2012;57(6):9-12.
2 China Tests Russian Antiviral Drug Which Might Treat Coronavirus As Moscow Warns Of Possible Mass Outbreak. February 5, 2020